Cargando…

Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome

BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamon, Annabelle, Scemama, Ugo, Bourenne, Jérémy, Daviet, Florence, Coiffard, Benjamin, Persico, Nicolas, Adda, Mélanie, Guervilly, Christophe, Hraiech, Sami, Chaumoitre, Kathia, Roch, Antoine, Papazian, Laurent, Forel, Jean-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437222/
https://www.ncbi.nlm.nih.gov/pubmed/30919111
http://dx.doi.org/10.1186/s13613-019-0516-9
_version_ 1783406920876425216
author Hamon, Annabelle
Scemama, Ugo
Bourenne, Jérémy
Daviet, Florence
Coiffard, Benjamin
Persico, Nicolas
Adda, Mélanie
Guervilly, Christophe
Hraiech, Sami
Chaumoitre, Kathia
Roch, Antoine
Papazian, Laurent
Forel, Jean-Marie
author_facet Hamon, Annabelle
Scemama, Ugo
Bourenne, Jérémy
Daviet, Florence
Coiffard, Benjamin
Persico, Nicolas
Adda, Mélanie
Guervilly, Christophe
Hraiech, Sami
Chaumoitre, Kathia
Roch, Antoine
Papazian, Laurent
Forel, Jean-Marie
author_sort Hamon, Annabelle
collection PubMed
description BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibroproliferative CT scan aspects in ARDS patients with high levels of NT-PCP-III. RESULTS: This retrospective study included ARDS patients who had at least one assessment of alveolar NT-PCP-III and a chest CT scan within 3 days before or after NT-PCP-III determination. An alveolar level of NT-PCP-III > 9 µG/L indicated fibroproliferation. The CT scan was scored on interstitial and alveolar abnormalities. Each lobe was scored from 0 to 5 according to the severity of the abnormalities. The crude score and the corrected score (related to the number of scored lobes in cases of important lobar condensation or lobectomy) were used. One hundred ninety-two patients were included, for a total of 228 alveolar NT-PCP-III level and CT scan ‘couples’. Crude and corrected CT scan fibrosis scores were higher in the fibroproliferation group compared with the no fibroproliferation group (crude score: 12 [9–17] vs 14 [11–12], p = 0.002; corrected score: 2.8 [2.2–4.0] vs 3.4 [2.5–4.7], p < 0.001). CT scan fibrosis scores and NT-PCP-III levels were significantly but weakly correlated (crude score: ρ = 0.178, p = 0.007; corrected score: ρ = 0.184, p = 0.005). CONCLUSIONS: When the alveolar level of NT-PCP-III was used as a surrogate marker of histological lung fibroproliferation, the CT scan fibrosis score was significantly higher in patients with active lung fibroproliferation. Pulmonary condensation is the main limitation to diagnosing fibroproliferation during ARDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13613-019-0516-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6437222
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-64372222019-04-15 Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome Hamon, Annabelle Scemama, Ugo Bourenne, Jérémy Daviet, Florence Coiffard, Benjamin Persico, Nicolas Adda, Mélanie Guervilly, Christophe Hraiech, Sami Chaumoitre, Kathia Roch, Antoine Papazian, Laurent Forel, Jean-Marie Ann Intensive Care Research BACKGROUND: Lung fibroproliferation in ARDS patients is associated with mortality. Alveolar procollagen III (NT-PCP-III) is a validated biomarker of lung fibroproliferation. A chest CT scan could be useful for the diagnosis of lung fibroproliferation. The aim of this study was to identify lung fibroproliferative CT scan aspects in ARDS patients with high levels of NT-PCP-III. RESULTS: This retrospective study included ARDS patients who had at least one assessment of alveolar NT-PCP-III and a chest CT scan within 3 days before or after NT-PCP-III determination. An alveolar level of NT-PCP-III > 9 µG/L indicated fibroproliferation. The CT scan was scored on interstitial and alveolar abnormalities. Each lobe was scored from 0 to 5 according to the severity of the abnormalities. The crude score and the corrected score (related to the number of scored lobes in cases of important lobar condensation or lobectomy) were used. One hundred ninety-two patients were included, for a total of 228 alveolar NT-PCP-III level and CT scan ‘couples’. Crude and corrected CT scan fibrosis scores were higher in the fibroproliferation group compared with the no fibroproliferation group (crude score: 12 [9–17] vs 14 [11–12], p = 0.002; corrected score: 2.8 [2.2–4.0] vs 3.4 [2.5–4.7], p < 0.001). CT scan fibrosis scores and NT-PCP-III levels were significantly but weakly correlated (crude score: ρ = 0.178, p = 0.007; corrected score: ρ = 0.184, p = 0.005). CONCLUSIONS: When the alveolar level of NT-PCP-III was used as a surrogate marker of histological lung fibroproliferation, the CT scan fibrosis score was significantly higher in patients with active lung fibroproliferation. Pulmonary condensation is the main limitation to diagnosing fibroproliferation during ARDS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13613-019-0516-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-03-27 /pmc/articles/PMC6437222/ /pubmed/30919111 http://dx.doi.org/10.1186/s13613-019-0516-9 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Hamon, Annabelle
Scemama, Ugo
Bourenne, Jérémy
Daviet, Florence
Coiffard, Benjamin
Persico, Nicolas
Adda, Mélanie
Guervilly, Christophe
Hraiech, Sami
Chaumoitre, Kathia
Roch, Antoine
Papazian, Laurent
Forel, Jean-Marie
Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title_full Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title_fullStr Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title_full_unstemmed Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title_short Chest CT scan and alveolar procollagen III to predict lung fibroproliferation in acute respiratory distress syndrome
title_sort chest ct scan and alveolar procollagen iii to predict lung fibroproliferation in acute respiratory distress syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437222/
https://www.ncbi.nlm.nih.gov/pubmed/30919111
http://dx.doi.org/10.1186/s13613-019-0516-9
work_keys_str_mv AT hamonannabelle chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT scemamaugo chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT bourennejeremy chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT davietflorence chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT coiffardbenjamin chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT persiconicolas chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT addamelanie chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT guervillychristophe chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT hraiechsami chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT chaumoitrekathia chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT rochantoine chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT papazianlaurent chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome
AT foreljeanmarie chestctscanandalveolarprocollageniiitopredictlungfibroproliferationinacuterespiratorydistresssyndrome